|
M.V. Novikova (1), M.G. Glezer (1, 2)
EFFECT OF TREATMENT WITH TRIMETAZIDINE ON INDICATORS OF EXERCISE TOLERANCE AND QUALITY OF LIFE OF PATIENTS WITH STABLE ANGINA RECEIVING OPTIMAL DRUG THERAPY
|
8-13 |
|
E.I. Astashkin, M.G. Glezer, N.S. Orekhova, N.D. Egorova, S.V. Grachev, I.N. Sokolova
INFLUENCE OF AKTOVEGIN ON BLOOD PHAGOCYTES IN OXIDATIVE STRESS IN PATIENTS WITH HEART FAILURE
|
14-19 |
|
A.V. Khripun, E.S. Godunko, A.I. Chesnikova
THE EFFECTS OF REVASCULARIZATION ON THE COURSE OF CORONARY ARTERY DISEASE IN POSTINFARCTION PERIOD IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
|
20-26 |
|
V.V. Skibitsky, E.V. Gorodetskaya, A.V. Fendrikova, E.A. Kudryashov
EFFICACY OF COMBINED ANTIHYPERTENSIVE THERAPY INCLUDING VARIOUS RENIN-ANGIOTENSIN SYSTEM INHIBITORS IN WOMEN WITH ARTERIAL HYPERTENSION AND CORONARY ARTERY DISEASE
|
27-32 |
|
P.R. Kamchatnov, A.V.Chugunov
METABOLIC THERAPY IN THE MANAGEMENT OF PATIENTS WITH ISCHEMIC STROKE
|
33-38 |
|
A.M. Shilov
SARTANS IN THE TREATMENT OF ARTERIAL HYPERTENSION IN THE PRACTICE OF PRIMARY CARE PHYSICIAN
|
39-44 |
|
O.V. Kotova, E.S. Akarachkova
NECK PAIN: PREVALENCE, RISK FACTORS,AND POTENTIALS FOR THERAPY
|
45-49 |
|
A.N. Bogolepova
COMPLIANCE TO THE TREATMENT OF DEMENTIA
|
50-54 |
|
O.A. Mubarakshina, M.N. Somova
MAGNESIUM IN THE COMPLEX THERAPY AND PREVENTION OF CARDIOVASCULAR DISEASES
|
55-58 |
|
A.N. Bogolepova
THERAPY OF EMOTIONAL AND COGNITIVE DISORDERS IN PATIENTS WITH CHRONIC CEREBRAL ISCHEMIA
|
59-64 |
|
L.O. Minushkina
MOXONIDINE IN THE TREATMENT OF ARTERIAL HYPERTENSION: EFFICIENCY IN COMBINATION THERAPY AND ADDITIONAL INDICATIONS
|
65-69 |
|
A.A. Kirichenko
BISOPROLOL AND CHRONIC HEART FAILURE
|
70-75 |
|
E.A. Ushkalova
VORAPAXAR – FIRST REPRESENTATIVE OF THE NEW CLASS OF ANTIPLATELETS
|
76-80 |
|
T.E. Morozova, T.B. Andruschishina
PREVENTION OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION
|
81-87 |
|
N.V. Chichasova
THE USE OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND RISK OF CARDIOVASCULAR COMPLICATIONS
|
88-95 |
Русский
